|
C1ORF55 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65401026208656E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.7750245717707E-12 |
| Normal-vs-Stage2 |
1.58549995354917E-09 |
| Normal-vs-Stage3 |
1.187730E-04 |
| Normal-vs-Stage4 |
4.09239999999977E-05 |
| Stage1-vs-Stage2 |
5.823200E-01 |
| Stage1-vs-Stage3 |
3.596500E-02 |
| Stage1-vs-Stage4 |
4.972800E-01 |
| Stage2-vs-Stage3 |
1.702030E-01 |
| Stage2-vs-Stage4 |
6.602000E-01 |
| Stage3-vs-Stage4 |
5.590600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.78512760129479E-12 |
| Normal-vs-AfricanAmerican |
1.61304303247789E-12 |
| Normal-vs-Asian |
2.28569999999317E-05 |
| Caucasian-vs-AfricanAmerican |
8.083400E-01 |
| Caucasian-vs-Asian |
6.141800E-01 |
| AfricanAmerican-vs-Asian |
6.411000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.78720000021393E-07 |
| Male-vs-Female |
2.275900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.10310000420466E-08 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
2.75950040595774E-10 |
| Normal-vs-Extreme_Obese |
9.85410000264864E-08 |
| Normal_Weight-vs-Extreme_Weight |
8.418200E-02 |
| Normal_Weight-vs-Obese |
9.956400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.280600E-01 |
| Extreme_Weight-vs-Obese |
1.594360E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.636000E-01 |
| Obese-vs-Extreme_Obese |
3.110600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.641700E-04 |
| Normal-vs-Age(41-60Yrs) |
1.47779566361805E-11 |
| Normal-vs-Age(61-80Yrs) |
2.66453525910038E-15 |
| Normal-vs-Age(81-100Yrs) |
4.73449945914695E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.748590E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.953900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.657750E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.036040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.673710E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.971200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
1.13910003651796E-09 |
| Normal-VS-KIRP CIMP |
3.279900E-02 |
| Normal-VS-Unclassified PRCC |
3.42089999660899E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.625950E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.001780E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.364300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.324790E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.358000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.078200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.85278484063656E-13 |
| Normal-vs-N1 |
3.284100E-03 |
| Normal-vs-N2 |
4.475800E-03 |
| N0-vs-N1 |
3.535100E-03 |
| N0-vs-N2 |
4.549000E-01 |
| N1-vs-N2 |
5.366400E-01 |
|
|
